Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Vasileios Petrakis"'
Autor:
Nikolina Antonopoulou, Georgios Schinas, Zoi Kotsiri, Olga Tsachouridou, Konstantinos Protopapas, Vasileios Petrakis, Emmanouil C. Petrakis, Despoina Papageorgiou, Dimosthenis Tzimotoudis, Simeon Metallidis, Antonios Papadopoulos, Markos Marangos, Emmanouil Barbounakis, Diamantis P. Kofteridis, Periklis Panagopoulos, Charalambos Gogos, Apostolos Vantarakis, Karolina Akinosoglou
Publikováno v:
Pathogens, Vol 13, Iss 7, p 536 (2024)
Hepatitis E virus (HEV) poses significant health concerns worldwide, particularly among people living with HIV (PLWHIV), due to an increased risk of chronic infection and progression to cirrhosis in individuals with low CD4 cell counts. This study ai
Externí odkaz:
https://doaj.org/article/c66e9bc6efb14b7db869ea3fe35cf25e
Autor:
Georgios Schinas, Nikolina Antonopoulou, Sofia Vamvakopoulou, Olga Tsachouridou, Konstantinos Protopapas, Vasileios Petrakis, Emmanouil C. Petrakis, Despoina Papageorgiou, Simeon Metallidis, Antonios Papadopoulos, Emmanouil Barbounakis, Diamantis Kofteridis, Periklis Panagopoulos, Alexandra Lekkou, Fotini Paliogianni, Karolina Akinosoglou
Publikováno v:
Viruses, Vol 16, Iss 7, p 1044 (2024)
This study assesses the prevalence of hepatitis D virus (HDV) in people living with HIV (PLWHIV) in Greece. Given the compounding effects of HDV and hepatitis B (HBV) on liver disease progression, as well as the emergence of new therapeutic options s
Externí odkaz:
https://doaj.org/article/4dcac820f3c54b728ecb1d6ddfe6343a
Autor:
Andreas G. Tsantes, Christos Koutserimpas, Symeon Naoum, Lida-Paraskevi Drosopoulou, Ellada Papadogeorgou, Vasileios Petrakis, Kalliopi Alpantaki, George Samonis, Enejd Veizi, Dimitrios V. Papadopoulos
Publikováno v:
Journal of Fungi, Vol 10, Iss 4, p 270 (2024)
Extrapulmonary infections by Coccidioides spp., though rare, can occur via dissemination, affecting singular or multiple sites, including the skin and musculoskeletal system. Skeletal involvement often manifests as osteomyelitis, particularly in the
Externí odkaz:
https://doaj.org/article/4bb05c691697463eb68a7078150c9608
Autor:
Andreas G. Tsantes, Dimitrios V. Papadopoulos, Stavros Goumenos, Ioannis G. Trikoupis, Konstantina A. Tsante, Christos Koutserimpas, Panagiotis Koulouvaris, Vasileios Petrakis, Aristeidis G. Vaiopoulos, Daniele Piovani, Georgios K. Nikolopoulos, Andreas F. Mavrogenis, Panayiotis J. Papagelopoulos, Stefanos Bonovas, Argirios E. Tsantes
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 7, p 1942 (2024)
Background/Objectives: There is a lack of reliable biomarkers for diagnosis of infection eradication prior to second-stage reimplantation in two-stage exchange arthroplasty for periprosthetic joint infections (PJIs). The aim of this study was to asse
Externí odkaz:
https://doaj.org/article/30629911db2c492284a050949122b983
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101785- (2023)
Summary: Background: The SAVE-MORE trial demonstrated that anakinra treatment in COVID-19 pneumonia with plasma soluble urokinase plasminogen activator (suPAR) levels of 6 ng/mL or more was associated with 0.36 odds for a worse outcome compared to pl
Externí odkaz:
https://doaj.org/article/849b622a96a44a189757b8aa960d5cf4
Autor:
Nikos Pantazis, Evmorfia Pechlivanidou, Anastasia Antoniadou, Karolina Akinosoglou, Ioannis Kalomenidis, Garyfallia Poulakou, Haralampos Milionis, Periklis Panagopoulos, Markos Marangos, Ioannis Katsarolis, Pinelopi Kazakou, Vasiliki Dimakopoulou, Anna-Louiza Chaliasou, Vasiliki Rapti, Eirini Christaki, Angelos Liontos, Vasileios Petrakis, Georgios Schinas, Dimitrios Biros, Maria-Christina Rimpa, Giota Touloumi
Publikováno v:
Microorganisms, Vol 11, Iss 8, p 1998 (2023)
Remdesivir was the first antiviral approved for treating COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective observational study of hospitalized adults who received remdesivi
Externí odkaz:
https://doaj.org/article/4d7eb4bd99eb4872959707740bb6624a
Autor:
Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, Eleni Karakike, Maria Saridaki, Georgia Loli, Aggelos Stefos, Danai Prasianaki, Sarah Georgiadou, Olga Tsachouridou, Vasileios Petrakis, Konstantinos Tsiakos, Maria Kosmidou, Vassiliki Lygoura, Maria Dareioti, Haralampos Milionis, Ilias C Papanikolaou, Karolina Akinosoglou, Dimitra-Melia Myrodia, Areti Gravvani, Aliki Stamou, Theologia Gkavogianni, Konstantina Katrini, Theodoros Marantos, Ioannis P Trontzas, Konstantinos Syrigos, Loukas Chatzis, Stamatios Chatzis, Nikolaos Vechlidis, Christina Avgoustou, Stamatios Chalvatzis, Miltiades Kyprianou, Jos WM van der Meer, Jesper Eugen-Olsen, Mihai G Netea, Evangelos J Giamarellos-Bourboulis
Publikováno v:
eLife, Vol 10 (2021)
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml were assigned to subcutaneous anakinra 100 mg once daily for 10 days.
Externí odkaz:
https://doaj.org/article/b6e14168181f411885ec741781944f9f
Autor:
Georgios Kassianidis, Athanasios Siampanos, Garyphalia Poulakou, George Adamis, Aggeliki Rapti, Haralampos Milionis, George N. Dalekos, Vasileios Petrakis, Styliani Sympardi, Symeon Metallidis, Zoi Alexiou, Theologia Gkavogianni, Evangelos J. Giamarellos-Bourboulis, Theoharis C. Theoharides
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 4894 (2022)
The trajectory from moderate and severe COVID-19 into acute respiratory distress syndrome (ARDS) necessitating mechanical ventilation (MV) is a field of active research. We determined serum levels within 24 h of presentation of 20 different sets of m
Externí odkaz:
https://doaj.org/article/1a7e0d9e9e8b40a7b2b1d936d0c53021
Autor:
Vasileios Petrakis, Paschalis Steiropoulos, Nikolaos Papanas, Grigorios Trypsianis, Dimitrios Papazoglou, Periklis Panagopoulos
Publikováno v:
International Journal of STD & AIDS. 34:191-202
Purpose Although HIV infection has become a chronic disease, people living with HIV (PLWHIV) often develop disorders that affect their quality of life. Sleep disturbances could occur in all stages of infection and lead to fatigue, increased risk for
Autor:
Nikos Pantazis, Evmorfia Pechlivanidou, Anastasia Antoniadou, Karolina Akinosoglou, Ioannis Kalomenidis, Garyfallia Poulakou, Haralampos Milionis, Periklis Panagopoulos, Ioannis Katsarolis, Pinelopi Kazakou, Vasiliki Dimakopoulou, Anna-Louiza Chaliasou, Vasiliki Rapti, Angelos Liontos, Vasileios Petrakis, Georgios Schinas, Dimitrios Biros, Maria-Christina Rimpa, Giota Touloumi
Background Remdesivir was the first antiviral approved for COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. Methods Retrospective observational study of hospitalized adults who received remdesivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a217f579f6595467d01a709f1474218e
https://doi.org/10.21203/rs.3.rs-2516706/v1
https://doi.org/10.21203/rs.3.rs-2516706/v1